Guidehealth vs Pearl Health (2026)
The AI Health Index reads this as a choice between an operator and a risk partner. Guidehealth sells an operating platform: STEM predictive targeting, RoseConnect, a voice AI that speaks with patients and escalates to people, Healthguides and nurses who carry out the work, and agentic AI for prior authorization and claims on the benefits side. Pearl sells prediction to Medicare primary care practices and takes on financial risk with them, paying implementation advances and monthly payments and pooling practices into shared savings and losses across ACO REACH, MSSP and Medicare Advantage. Choose Guidehealth where the constraint is people to do the outreach and an external review of AI governance counts. Choose Pearl where a practice wants a partner to carry part of the Medicare risk and a certified platform to target against. Both publish results without a method, and both sets of terms provide the service as is and exclude liability. One thing a buyer should know: a model that predicts cost ranks patients by what they will spend rather than what they need, and neither vendor publishes how its ranking performs across patient groups.
- Guidehealth holds URAC's Health Care AI Accreditation, and URAC's August 2026 announcement named it among the first organizations to earn it. An accrediting body has examined how the company governs its AI use against a published standard. The AI Health Index records no equivalent external review of AI governance for Pearl.
- Guidehealth supplies the people as well as the prediction. Healthguides and nurses act on what STEM targets, and RoseConnect escalates to them when judgment is needed, so a network that cannot staff outreach is buying the capacity it lacks.
- Guidehealth sells beyond Medicare primary care, to health systems, payers and employers, and covers benefits administration, including prior authorization and claims, alongside care management.
- Pearl holds HITRUST r2 certification for the Pearl Health Application, announced on its own blog in March 2025. Guidehealth publishes no security attestation on its home, solution, privacy or terms pages.
- Pearl takes on risk with its practices through implementation advances, predictable monthly payments and pooled shared savings and losses. That ties its money to the practice's results, though it is not a commitment to the practice about any prediction, since the practice shares the losses too.
- Pearl names its customers, among them BayCare Health System, Holzer Health System and Hudson Headwaters, and states its scale: 250,000 beneficiaries and 10,000 providers in more than 40 states. Guidehealth's home page results name no customer.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Guidehealth and Pearl Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Guidehealth | Pearl Health |
|---|---|---|
| Primary category | Value Based Care Intelligence | Value Based Care Intelligence |
| Founded | 2023 | Not recorded |
| Headquarters | Dallas, Texas, United States | New York, New York |
| Website | guidehealth.com | pearlhealth.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Guidehealth
-
Security / compliance
Guidehealth became one of the first organizations to earn the new Health Care AI Accreditation from URAC.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Guidehealth is a Dallas based operating platform for value based care and benefits administration, formed in 2023 and built partly on the acquired value based care services division of an analytics vendor. It sells to health systems and doctors, payers and employers under two pillars.
Source: AI Health Index, September 2026
Pearl Health is a New York value based care enablement company for Medicare primary care. Its platform analyses claims, ADT feeds and record system data to rank the patients who need attention first, suggests next steps such as follow ups and diagnosis gaps, automates routine outreach and scheduling, and tracks cost, quality and benchmark performance; its actuarial and data science teams match practices to the Medicare program and risk level that suits them across ACO REACH, MSSP and Medicare Advantage.
Source: AI Health Index, September 2026
Questions buyers ask
Which settings and specialties do Guidehealth and Pearl Health cover?
For Guidehealth, results on the home page are reported for the health system and value based contract side (admissions, readmissions, savings, star ratings).
With Pearl Health, the scope is Medicare primary care: health systems, physician networks and independent practices in ACO REACH, MSSP and Medicare Advantage, with the company reporting 250,000 beneficiaries, 10,000 providers and more than 40 states. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 21, 2026. No vendor pays for placement.
What evidence is published for Guidehealth and Pearl Health?
In Guidehealth's case, the company itself is the only source for all of it. No baseline, comparison group, period, population size or customer accompanies any figure, and a star rating gain in six months is hard to attribute to one vendor against plan wide changes.
For Pearl Health, customers quoted by name include BayCare Health System, Holzer Health System, Santé Physicians, Hudson Headwaters, PraxisCare, MDX Hawaii, Virginia Care Partners, BlueSky MD and Odibo Medical Group. The company is the claimed source, and no baseline, period, population or method accompanies the figures; the quotes describe the partnership rather than measured outcomes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 21, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Neither vendor publishes a price. Guidehealth describes a staffed operating relationship and Pearl describes risk arrangements, so what drives the cost is unstated on both sides: Guidehealth's unit of charge, and Pearl's split of savings and losses and whether advances are repaid from savings.
Both publish results with no method. Guidehealth's home page reports lower admissions and readmissions and 8 percent average savings on commercial contracts, with no baseline or named customer, and Pearl's savings figures carry no method either. Both sets of terms provide the service as is, disclaim accuracy and exclude liability. Neither publishes where its system runs.
Guidehealth's RoseConnect speaks with patients directly, and its prior authorization decisioning is marketed as running in minutes and straight through, with human oversight described only as a phrase. Pearl documents its prioritization algorithm only in a gated report and publishes no business associate agreement or platform privacy terms.
Ask both how prioritization performs across race, language and income, since patients a cost model ranks too low never appear in its metrics. Ask Guidehealth what RoseConnect may say and when a person reviews an authorization decision. Ask Pearl for the savings and loss split and the business associate terms.